Progeria: A paradigm for translational medicine

Cell

Volumn 156, Issue 3, 2014, Pages 400-407

  Gordon, Leslie B ^a,b   Rothman, Frank G ^c   López Otín, Carlos ^d   Misteli, Tom ^e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LAMIN A; LONAFARNIB; PRAVASTATIN; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RESVERATROL; RNA; ZOLEDRONIC ACID;

CELL FUNCTION; CELL STRUCTURE; CELLULAR STRESS RESPONSE; CHROMOSOME; CLINICAL TRIAL (TOPIC); CYTOLOGY; DRUG REPOSITIONING; GENE THERAPY; HISTORY OF MEDICINE; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PREMATURE AGING; PRIORITY JOURNAL; PROGERIA; RARE DISEASE; REVIEW; RNA TRANSLATION; STEM CELL TRANSPLANTATION; ADIPOGENESIS; AGING; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL NUCLEUS; CHILDHOOD DISEASE; CHROMATIN STRUCTURE; CLINICAL MEDICINE; CLINICAL RESEARCH; DRUG DEVELOPMENT; EPIGENETICS; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; LAMINOPATHY; PROTEIN PROCESSING; RNA THERAPY; THERAPY; TRANSLATIONAL RESEARCH;

AGING; CHILD; FARNESYLTRANSTRANSFERASE; HUMANS; NUCLEAR PROTEINS; PROGERIA; PROTEIN PRECURSORS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84893431595     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2013.12.028     Document Type: Note

References (74)

1. P.B. Baker, N. Baba, and C.P. Boesel Cardiovascular abnormalities in progeria. Case report and review of the literature Arch. Pathol. Lab. Med. 105 1981 384 386
2. E.K. Benson, S.W. Lee, and S.A. Aaronson Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence J. Cell Sci. 123 2010 2605 2612
3. B. Burke, and C.L. Stewart The nuclear lamins: flexibility in function Nat. Rev. Mol. Cell Biol. 14 2013 13 24
4. C.R. Burtner, and B.K. Kennedy Progeria syndromes and ageing: what is the connection? Nat. Rev. Mol. Cell Biol. 11 2010 567 578
5. K. Cao, C.D. Blair, D.A. Faddah, J.E. Kieckhaefer, M. Olive, M.R. Erdos, E.G. Nabel, and F.S. Collins Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts J. Clin. Invest. 121 2011 2833 2844
6. K. Cao, J.J. Graziotto, C.D. Blair, J.R. Mazzulli, M.R. Erdos, D. Krainc, and F.S. Collins Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells Sci. Transl. Med. 3 2011 89ra58
7. B.C. Capell, M.R. Erdos, J.P. Madigan, J.J. Fiordalisi, R. Varga, K.N. Conneely, L.B. Gordon, C.J. Der, A.D. Cox, and F.S. Collins Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome Proc. Natl. Acad. Sci. USA 102 2005 12879 12884
8. B.C. Capell, M. Olive, M.R. Erdos, K. Cao, D.A. Faddah, U.L. Tavarez, K.N. Conneely, X. Qu, H. San, and S.K. Ganesh et al. A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model Proc. Natl. Acad. Sci. USA 105 2008 15902 15907
9. V. Cenni, C. Capanni, M. Columbaro, M. Ortolani, M.R. D'Apice, G. Novelli, M. Fini, S. Marmiroli, E. Scarano, and N.M. Maraldi et al. Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria Eur. J. Histochem. 55 2011 e36
10. J.C. Choi, A. Muchir, W. Wu, S. Iwata, S. Homma, J.P. Morrow, and H.J. Worman Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation Sci. Transl. Med. 4 2012 144ra102
11. R.H. Cleveland, L.B. Gordon, M.E. Kleinman, D.T. Miller, C.M. Gordon, B.D. Snyder, A. Nazarian, A. Giobbie-Hurder, D. Neuberg, and M.W. Kieran A prospective study of radiographic manifestations in Hutchinson-Gilford progeria syndrome Pediatr. Radiol. 42 2012 1089 1098
12. K.N. Dahl, A. Kalinowski, and K. Pekkan Mechanobiology and the microcirculation: cellular, nuclear and fluid mechanics Microcirculation 17 2010 179 191
13. J. de la Rosa, J.M. Freije, R. Cabanillas, F.G. Osorio, M.F. Fraga, M.S. Fernandez-Garcia, R. Rad, V. Fanjul, A.P. Ugalde, and Q. Liang et al. Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion Nat. Commun. 4 2013 2268
14. A. De Sandre-Giovannoli, R. Bernard, P. Cau, C. Navarro, J. Amiel, I. Boccaccio, S. Lyonnet, C.L. Stewart, A. Munnich, M. Le Merrer, and N. Lévy Lamin a truncation in Hutchinson-Gilford progeria Science 300 2003 2055
15. M. Eriksson, W.T. Brown, L.B. Gordon, M.W. Glynn, J. Singer, L. Scott, M.R. Erdos, C.M. Robbins, T.Y. Moses, and P. Berglund et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome Nature 423 2003 293 298
16. J. Espada, I. Varela, I. Flores, A.P. Ugalde, J. Cadiñanos, A.M. Pendás, C.L. Stewart, K. Tryggvason, M.A. Blasco, J.M. Freije, and C. López-Otín Nuclear envelope defects cause stem cell dysfunction in premature-aging mice J. Cell Biol. 181 2008 27 35
17. L.G. Fong, D. Frost, M. Meta, X. Qiao, S.H. Yang, C. Coffinier, and S.G. Young A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria Science 311 2006 1621 1623
18. M. Gerhard-Herman, L.B. Smoot, N. Wake, M.W. Kieran, M.E. Kleinman, D.T. Miller, A. Schwartzman, A. Giobbie-Hurder, D. Neuberg, and L.B. Gordon Mechanisms of premature vascular aging in children with Hutchinson-Gilford progeria syndrome Hypertension 59 2012 92 97
19. H. Gilford Progeria: A form of senilism Practitioner 73 1904 188 217
20. M.W. Glynn, and T.W. Glover Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition Hum. Mol. Genet. 14 2005 2959 2969
21. R.D. Goldman, D.K. Shumaker, M.R. Erdos, M. Eriksson, A.E. Goldman, L.B. Gordon, Y. Gruenbaum, S. Khuon, M. Mendez, R. Varga, and F.S. Collins Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome Proc. Natl. Acad. Sci. USA 101 2004 8963 8968
22. Gordon, L.B. (2013). PRF By The Numbers (The Progeria Research Foundation). http://www.progeriaresearch.org/prf-by-the-numbers.html.
23. L.B. Gordon, I.A. Harten, M.E. Patti, and A.H. Lichtenstein Reduced adiponectin and HDL cholesterol without elevated C-reactive protein: clues to the biology of premature atherosclerosis in Hutchinson-Gilford Progeria Syndrome J. Pediatr. 146 2005 336 341
24. C.M. Gordon, L.B. Gordon, B.D. Snyder, A. Nazarian, N. Quinn, S. Huh, A. Giobbie-Hurder, D. Neuberg, R. Cleveland, and M. Kleinman et al. Hutchinson-Gilford progeria is a skeletal dysplasia J. Bone Miner. Res. 26 2011 1670 1679
25. L.B. Gordon, M.E. Kleinman, D.T. Miller, D.S. Neuberg, A. Giobbie-Hurder, M. Gerhard-Herman, L.B. Smoot, C.M. Gordon, R. Cleveland, and B.D. Snyder et al. Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome Proc. Natl. Acad. Sci. USA 109 2012 16666 16671
26. J. Halaschek-Wiener, and A. Brooks-Wilson Progeria of stem cells: stem cell exhaustion in Hutchinson-Gilford progeria syndrome J. Gerontol. A Biol. Sci. Med. Sci. 62 2007 3 8
27. G.E. Havelka, and M.R. Kibbe The vascular adventitia: its role in the arterial injury response Vasc. Endovascular Surg. 45 2011 381 390
28. F.M. Hisama, D. Lessel, D. Leistritz, K. Friedrich, K.L. McBride, M.T. Pastore, G.S. Gottesman, B. Saha, G.M. Martin, C. Kubisch, and J. Oshima Coronary artery disease in a Werner syndrome-like form of progeria characterized by low levels of progerin, a splice variant of lamin A Am. J. Med. Genet. A. 155A 2011 3002 3006
29. S. Huang, L. Chen, N. Libina, J. Janes, G.M. Martin, J. Campisi, and J. Oshima Correction of cellular phenotypes of Hutchinson-Gilford Progeria cells by RNA interference Hum. Genet. 118 2005 444 450
30. J. Hutchinson Congenital absence of hair and mammary glands with atrophic condition of the skin and its appendages Med. Chir. Trans. 69 1886 473 477
31. M.X. Ibrahim, V.I. Sayin, M.K. Akula, M. Liu, L.G. Fong, S.G. Young, and M.O. Bergo Targeting isoprenylcysteine methylation ameliorates disease in a mouse model of progeria Science 340 2013 1330 1333
32. H.J. Jung, C. Coffinier, Y. Choe, A.P. Beigneux, B.S. Davies, S.H. Yang, R.H. Barnes 2nd, J. Hong, T. Sun, and S.J. Pleasure et al. Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA Proc. Natl. Acad. Sci. USA 109 2012 E423 E431
33. M.W. Kieran, L. Gordon, and M. Kleinman New approaches to progeria Pediatrics 120 2007 834 841
34. A.A. King, and G.L. Heyer Moving from gene discovery to clinical trials in Hutchinson-Gilford progeria syndrome Neurology 81 2013 408 409
35. R. Kole, A.R. Krainer, and S. Altman RNA therapeutics: beyond RNA interference and antisense oligonucleotides Nat. Rev. Drug Discov. 11 2012 125 140
36. B.A. Kudlow, M.N. Stanfel, C.R. Burtner, E.D. Johnston, and B.K. Kennedy Suppression of proliferative defects associated with processing-defective lamin A mutants by hTERT or inactivation of p53 Mol. Biol. Cell 19 2008 5238 5248
37. Y. Liu, A. Rusinol, M. Sinensky, Y. Wang, and Y. Zou DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A J. Cell Sci. 119 2006 4644 4649
38. G.H. Liu, K. Suzuki, J. Qu, I. Sancho-Martinez, F. Yi, M. Li, S. Kumar, E. Nivet, J. Kim, and R.D. Soligalla et al. Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs Cell Stem Cell 8 2011 688 694
39. B. Liu, S. Ghosh, X. Yang, H. Zheng, X. Liu, Z. Wang, G. Jin, B. Zheng, B.K. Kennedy, and Y. Suh et al. Resveratrol rescues SIRT1-dependent adult stem cell decline and alleviates progeroid features in laminopathy-based progeria Cell Metab. 16 2012 738 750
40. Y. Liu, I. Drozdov, R. Shroff, L.E. Beltran, and C.M. Shanahan Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells Circ. Res. 112 2013 e99 e109
41. C. López-Otín, M.A. Blasco, L. Partridge, M. Serrano, and G. Kroemer The hallmarks of aging Cell 153 2013 1194 1217
42. N.C. Mackenzie, and V.E. MacRae The role of cellular senescence during vascular calcification: a key paradigm in aging research Curr. Aging Sci. 4 2011 128 136
43. M.P. Mallampalli, G. Huyer, P. Bendale, M.H. Gelb, and S. Michaelis Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome Proc. Natl. Acad. Sci. USA 102 2005 14416 14421
44. G. Mariño, A.P. Ugalde, N. Salvador-Montoliu, I. Varela, P.M. Quirós, J. Cadiñanos, I. van der Pluijm, J.M. Freije, and C. López-Otín Premature aging in mice activates a systemic metabolic response involving autophagy induction Hum. Mol. Genet. 17 2008 2196 2211
45. G. Mariño, A.P. Ugalde, A.F. Fernández, F.G. Osorio, A. Fueyo, J.M. Freije, and C. López-Otín Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function Proc. Natl. Acad. Sci. USA 107 2010 16268 16273
46. D. McClintock, D. Ratner, M. Lokuge, D.M. Owens, L.B. Gordon, F.S. Collins, and K. Djabali The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin PLoS ONE 2 2007 e1269
47. R.P. McCord, A. Nazario-Toole, H. Zhang, P.S. Chines, Y. Zhan, M.R. Erdos, F.S. Collins, J. Dekker, and K. Cao Correlated alterations in genome organization, histone methylation, and DNA-lamin A/C interactions in Hutchinson-Gilford progeria syndrome Genome Res. 23 2013 260 269
48. M.A. Merideth, L.B. Gordon, S. Clauss, V. Sachdev, A.C. Smith, M.B. Perry, C.C. Brewer, C. Zalewski, H.J. Kim, and B. Solomon et al. Phenotype and course of Hutchinson-Gilford progeria syndrome N. Engl. J. Med. 358 2008 592 604
49. P.R. Musich, and Y. Zou Genomic instability and DNA damage responses in progeria arising from defective maturation of prelamin A Aging (Albany, N.Y. Online) 1 2009 28 37
50. X. Nissan, S. Blondel, C. Navarro, Y. Maury, C. Denis, M. Girard, C. Martinat, A. De Sandre-Giovannoli, N. Levy, and M. Peschanski Unique preservation of neural cells in Hutchinson- Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA Cell Rep. 2 2012 1 9
51. M. Olive, I. Harten, R. Mitchell, J.K. Beers, K. Djabali, K. Cao, M.R. Erdos, C. Blair, B. Funke, and L. Smoot et al. Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging Arterioscler. Thromb. Vasc. Biol. 30 2010 2301 2309
52. F.G. Osorio, C.L. Navarro, J. Cadinanos, I.C. Lopez-Mejia, P.M. Quiros, C. Bartoli, J. Rivera, J. Tazi, G. Guzman, and I. Varela et al. Splicing-directed therapy in a new mouse model of human accelerated aging Sci. Transl. Med. 3 2011 106ra107
53. F.G. Osorio, C. Bárcena, C. Soria-Valles, A.J. Ramsay, F. de Carlos, J. Cobo, A. Fueyo, J.M. Freije, and C. López-Otín Nuclear lamina defects cause ATM-dependent NF-κB activation and link accelerated aging to a systemic inflammatory response Genes Dev. 26 2012 2311 2324
54. G. Pegoraro, N. Kubben, U. Wickert, H. Göhler, K. Hoffmann, and T. Misteli Ageing-related chromatin defects through loss of the NURD complex Nat. Cell Biol. 11 2009 1261 1267
55. C.H. Pui, A.J. Gajjar, J.R. Kane, I.A. Qaddoumi, and A.S. Pappo Challenging issues in pediatric oncology Nat. Rev. Clin. Oncol. 8 2011 540 549
56. C.D. Ragnauth, D.T. Warren, Y. Liu, R. McNair, T. Tajsic, N. Figg, R. Shroff, J. Skepper, and C.M. Shanahan Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging Circulation 121 2010 2200 2210
57. F.J. Ramos, S.C. Chen, M.G. Garelick, D.F. Dai, C.Y. Liao, K.H. Schreiber, V.L. MacKay, E.H. An, R. Strong, and W.C. Ladiges et al. Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival Sci. Transl. Med. 4 2012 144ra103
58. S. Rodriguez, F. Coppedè, H. Sagelius, and M. Eriksson Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging Eur. J. Hum. Genet. 17 2009 928 937
59. Y. Rosengardten, T. McKenna, D. Grochová, and M. Eriksson Stem cell depletion in Hutchinson-Gilford progeria syndrome Aging Cell 10 2011 1011 1020
60. P. Scaffidi, and T. Misteli Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome Nat. Med. 11 2005 440 445
61. P. Scaffidi, and T. Misteli Lamin A-dependent nuclear defects in human aging Science 312 2006 1059 1063
62. P. Scaffidi, and T. Misteli Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing Nat. Cell Biol. 10 2008 452 459
63. V.M. Silvera, L.B. Gordon, D.B. Orbach, S.E. Campbell, J.T. Machan, and N.J. Ullrich Imaging characteristics of cerebrovascular arteriopathy and stroke in Hutchinson-Gilford progeria syndrome AJNR Am. J. Neuroradiol. 34 2013 1091 1097
64. M. Sinensky, K. Fantle, M. Trujillo, T. McLain, A. Kupfer, and M. Dalton The processing pathway of prelamin A J. Cell Sci. 107 1994 61 67
65. J.I. Toth, S.H. Yang, X. Qiao, A.P. Beigneux, M.H. Gelb, C.L. Moulson, J.H. Miner, S.G. Young, and L.G. Fong Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes Proc. Natl. Acad. Sci. USA 102 2005 12873 12878
66. A.P. Ugalde, A.J. Ramsay, J. de la Rosa, I. Varela, G. Mariño, J. Cadiñanos, J. Lu, J.M. Freije, and C. López-Otín Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53 EMBO J. 30 2011 2219 2232
67. N.J. Ullrich, M.W. Kieran, D.T. Miller, L.B. Gordon, Y.J. Cho, V.M. Silvera, A. Giobbie-Hurder, D. Neuberg, and M.E. Kleinman Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment Neurology 81 2013 427 430
68. I. Varela, J. Cadiñanos, A.M. Pendás, A. Gutiérrez-Fernández, A.R. Folgueras, L.M. Sánchez, Z. Zhou, F.J. Rodríguez, C.L. Stewart, and J.A. Vega et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation Nature 437 2005 564 568
69. I. Varela, S. Pereira, A.P. Ugalde, C.L. Navarro, M.F. Suárez, P. Cau, J. Cadiñanos, F.G. Osorio, N. Foray, and J. Cobo et al. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging Nat. Med. 14 2008 767 772
70. V. Wenzel, D. Roedl, D. Gabriel, L.B. Gordon, M. Herlyn, R. Schneider, J. Ring, and K. Djabali Naïve adult stem cells from patients with Hutchinson-Gilford progeria syndrome express low levels of progerin in vivo Biol. Open 1 2012 516 526
71. H.J. Worman, and G. Bonne "Laminopathies": a wide spectrum of human diseases Exp. Cell Res. 313 2007 2121 2133
72. S.H. Yang, M.O. Bergo, J.I. Toth, X. Qiao, Y. Hu, S. Sandoval, M. Meta, P. Bendale, M.H. Gelb, S.G. Young, and L.G. Fong Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation Proc. Natl. Acad. Sci. USA 102 2005 10291 10296
73. S.H. Yang, X. Qiao, L.G. Fong, and S.G. Young Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson-Gilford progeria syndrome mutation Biochim. Biophys. Acta 1781 2008 36 39
74. J. Zhang, Q. Lian, G. Zhu, F. Zhou, L. Sui, C. Tan, R.A. Mutalif, R. Navasankari, Y. Zhang, and H.F. Tse et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects Cell Stem Cell 8 2011 31 45